Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice

Journal of Chemical Neuroanatomy

Volumn 44, Issue 2, 2012, Pages 76-85

  Vivacqua, Giorgio ^a,c   Biagioni, Francesca ^b   Yu, Shun ^c,d   Casini, Arianna ^a   Bucci, Domenico ^b   D'Este, Loredana ^a   Fornai, Francesco ^b,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Amyotrophic Lateral Sclerosis; Immunohistochemistry; Neurodegeneration; Parkinson Disease; Spinal cord

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; EPITOPE; MONOCLONAL ANTIBODY; TYROSINE 3 MONOOXYGENASE;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MOTONEURON; MOUSE; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SPINAL CORD NERVE CELL; SPINAL MOTOR NEURON; STEREOLOGY; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA PARS COMPACTA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; CELL COUNT; CORPUS STRIATUM; DOPAMINERGIC NEURONS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MOTOR NEURONS; MPTP POISONING; NERVE DEGENERATION; SPINAL CORD; STEREOTAXIC TECHNIQUES; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84864023125     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2012.04.003     Document Type: Article

References (61)

1. Alim M.A., Ma Q.L., Tokeda K., Alzawa T., Matsubara M., Nakamura M., Asada A., Saito T., Kaji H., Yoshii M., Hisanaga S., Uéda K. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. Journal of Alzheimer's Disease 2004, 6:435-442.
2. Andreassen O.A., Ferrante R.J., Klivenyi P., Klein A.M., Dedeoglu A., Albers D.S., Kowall N.W., Beal M.F. Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Experimental Neurology 2001, 168(2):356-363.
3. Braak H., Sastre M., Bohl J.R., de Vos R.A., Del Tredici K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathologica 2007, 113(4):421-429.
4. Bredensen D.E., Rao R.V., Mehlen P. Cell death in the nervous system. Nature 2006, 443:796-802.
5. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507-511.
6. Chandra S., Gallardo G., Fernandez-Chacon R., Schlüter O.M., Südhof T.C. Alpha-synuclein cooperates with CSP-alpha in preventing neurodegeneration. Cell 2005, 123:383-396.
7. Chang Q., Martin L.J. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis. American Journal of Pathology 2009, 174(2):574-585.
8. Cheng F., Vivacqua G., Yu S. The role of alpha-synuclein in neurotransmission and synaptic plasticity. Journal of Chemical Neuroanatomy 2011, 42(4):242-248.
9. Chera B., Schaecher K.E., Rocchini A., Imam S.Z., Ray S.K., Ali S.F., Banik N.L. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Annals of the New York Academy of Sciences 2002, 965:274-280.
10. Chera B., Schaecher K.E., Rocchini A., Imam S.Z., Sribnick E.A., Ray S.K., Ali S.F., Banik N.L. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Brain Research 2004, 1006(2):150-156.
11. Chiba K., Trevor A., Castagnoli N. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochemical and Biophysical Research Communications 1984, 120:574-578.
12. Ciechanover A. The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology 2006, 66:S7-S19.
13. D'Andrea M.R., Ilyin S., Plata-Salaman C.R. Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantianigra brain tissues. Neuroscience Letters 2001, 306(3):137-140.
14. Engelender S., Kaminsky Z., Guo X., Sharp A.H., Amaravi R.K., Kleiderlein J.J., Margolis R.L., Troncoso J.C., Lanahan A.A., Worley P.F., Dawson V.L., Dawson T.M., Ross C.A. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nature Genetics 1999, 22(1):110-114.
15. Ferrucci M., Pasquali L., Ruggieri S., Paparelli A., Fornai F. Alpha-synuclein and autophagy as common steps in neurodegeneration. Parkinsonism & Related Disorders 2008, 2(14 Suppl.):S180-S184.
16. Ford B. Pain in Parkinson's disease. Movement Disorders 2010, 25(Suppl. 1):S98L 103.
17. Fornai F., Bassi L., Bonaccorsi I., Giorgi F., Corsini G.U. Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents. Functional Neurology 1997, 12(3-4):193-198.
18. Fornai F., Longone P., Cafaro L., Kastsiuchenka O., Ferrucci M., Manca M.L., Lazzeri G., Spallone A., Bellio N., Lenzi P., Modugno N., Siciliano G., Isidoro C., Murri L., Ruggieri S., Paparelli A. Lithium delays progression of amyotrophic lateral sclerosis. Procedings of the National Academy of Science of the United States of America 2008, 105(6):2052-2057.
19. Fornai F., Schlüter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., Lazzeri G., Busceti C.L., Pontarelli F., Battaglia G., Pellegrini A., Nicoletti F., Ruggieri S., Paparelli A., Südhof T.C. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha synuclein. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:3413-3418.
20. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2010, Academic Press. fourth ed.
21. Gesi M., Soldani P., Giorgi F.S., Santinami A., Bonaccorsi I., Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neuroscience and Biobehavioral Reviews 2000, 24(6):655-668.
22. Gilbert R.M., Fahn M., Mitsumoto H., Rowland L.P. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Movement Disorders 2010, 25(12):1868-1875.
23. Giorgi F.S., Bandettini di Poggio A., Battaglia G., Pellegrini A., Murri L., Ruggieri S., Paparelli A., Fornai F. A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease. Journal of Neural Transmission Supplementum 2006, (70):105-109.
24. Gundersen H.J.G., Jensen E.B.V., Kiêu K., Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. Journal of Microscopy 1999, 193:199-211.
25. Heikkila R.E., Sieber B.A., Manzino L., Sonsalla P.K. Some features of the nigrostriatal neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Molecular and Chemical Neuropathology 1989, 10(3):171-183.
26. Jensen P.H., Hager H., Nielsen M.S., Hojrup P., Gliemann J., Jakes R. alpha-Synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. Journal of Biological Chemistry 1999, 274:25481-25489.
27. Jensen P.H., Islam K., Kenney J., Nielsen M.S., Power J., Gai W.P. Microtubule associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. Journal of Biological Chemistry 2000, 275(28):21500-21507.
28. King M.A., Scotty N., Klein R.L., Meyer E.M. Particle detection, number estimation and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysis. Methods 2002, 28:293-299.
29. Kontopoulos E., Parvin J.D., Feany M.B. α-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Human Molecular Genetics 2006, 15(20):3012-3023.
30. Korczyn A.D., Gurevich T. Parkinson's disease: before the motor symptoms and beyond. Journal of the Neurological Science 2010, 289(1-2):2-6.
31. Kühn K., Wellen S., Link N., Maskri L., Lubbert H., Stichel C.C. The mouse MPTP model: gene expression changes in DA neurons. European Journal of Neuroscience 2003, 17(1):1-12.
32. Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 1984, 311:464-467.
33. Martin L.J. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration. Reviews in the Neurosciences 2007, 18(2):115-136.
34. Martin L.J., Pan Y., Price A.C., Sterling W., Copeland N.G., Jenkins N.A., Price D.L., Lee M.K. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. Journal of Neuroscience 2006, 26(1):41-50.
35. Mayer R.A., Walters A.S., Heikkila R.E. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity. European Journal of Pharmacology 1986, 120(3):375-377.
36. Meredith G.E., Totterdell S., Potashkin J.A., Surmeier D.J. Modelling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism & Related Disorders 2008, 14(Suppl. 2):S112-S115.
37. Najim al-Din A.S., Wriekat A., Mubaidin A., Dasouki M., Hiari M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurologica Scandinavica 1994, 89(5):347-352.
38. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annual Review of Neuroscience 1999, 22:123-144.
39. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurology 2003, 2:107-116.
40. Purisai M.G., McCormack A.L., Langston W.J., Johnston L.C., Di Monte D.A. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiology of Disease 2005, 20(3):898-906.
41. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews 2010, 90:1383-1435.
42. Samantaray S., Butler J.T., Ray S.K., Banik N.L. Extranigral neurodegeneration in Parkinson's disease. Annals of the New York Academy of Sciences 2008, 1139:331-336.
43. Samantaray S., Knaryan V.H., Butler J.T., Ray S.K., Banik N.L. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP. Journal of Neurochemistry 2008, 104:1309-1320.
44. Samantaray S., Knaryan V.H., Guyton M.K., Matzelle D.D., Ray S.K., Banik N.L. The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneurons degeneration in spinal cord of Lewis rats. Neuroscience 2007, 146:741-755.
45. Savica R., Carlin J.M., Grossardt B.R., Bower J.H., Ahlskog J.E., Maraganore D.M., Bharucha A.E., Rocca W.A. Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology 2009, 73(21):1752-1758.
46. Sharma N., Hewett J., Ozelius L.J., Ramesh V., McLean P.J., Breakefield X.O., Hyman B.T. A close association of TorsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. American Journal of Pathology 2001, 159(1):339-344.
47. Sonsalla P.K., Heikkila R.E. The influence of dose and dosing interval on MPTP induced dopaminergic neurotoxicity in mice. European Journal of Pharmacology 1986, 129(3):339-345.
48. Stefanis L., Larsen K.E., Rideout H.J., Sulzer D., Greene L.A. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. Journal of Neuroscience 2001, 21:9549-9560.
49. Tanaka Y., Engelender S., Igarashi S., Rao R.K., Wanner T., Tanzi R.E., Sawa A.L., Dawson V., Dawson T.M., Ross C.A. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Human Molecular Genetics 2001, 10:919-926.
50. Tong J., Hornykiewicz O., Kish S.J. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Archives of Neurology 2006, 63:1724-1728.
51. Trojanowski J.Q., Ishihara T., Higuchi M., Yoshiyama Y., Hong M., Zhang B., Forman M.S., Zhukareva V., Lee V.M. Amyotrophic lateral sclerosis/parkinsonism dementia complex: transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam. Experimental Neurology 2002, 176(1):1-11.
52. Vivacqua G., Casini A., Vaccaro R., Fornai F., Yu S., D'Este L. Different sub-cellular localization of alpha-synuclein in the C57BL/6J mouse's central nervous system by two novel monoclonal antibodies. Journal of Chemical Neuroanatomy 2011, 41(2):97-110.
53. Vivacqua G., Casini A., Vaccaro R., Parisi Salvi E., Pasquali L., Fornai F., Yu S., D'Este L. Spinal cord and Parkinsonism: neuromorphological evidences in humans and experimental studies. Journal of Chemical Neuroanatomy 2011, 42(4):327-340.
54. Vivacqua G., Yin J.J., Casini A., Li X., Li Y.H., D'Este L., Chan P., Renda T.G., Yu S. Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies. Neuroscience 2009, 158(4):1478-1487.
55. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
56. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., Lansbury P.T. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 1996, 35(43):13709-13715.
57. West M.J., Slomianka L., Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons in the subdivisions of rat hippocampus using the optical fractionator. Anatomical Record 1991, 231:482-497.
58. Yu S., Li X., Liu G., Han J., Zhang C., Li Y., Xu S., Liu C., Gao Y., Yang H., Uèda K., Chan P. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 2007, 145:539-555.
59. Yu S., Uéda K., Chan P. α-Synuclein and dopamine metabolism. Molecular Neurobiology 2005, 31:243-254.
60. Zarow C., Lyness S.A., Mortimer J.A., Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantianigra in Alzheimer and Parkinson diseases. Archives of Neurology 2003, 60(3):337-341.
61. Zhou R.M., Huang Y.X., Li X.L., Chen C., Shi Q., Wang G.R., Tian C., Wang Z.Y., Jing Y.Y., Gao C., Dong X.P. Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells. Molecular Biology Reports 2010, 37(7):3183-3192.